Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris

Summary

The current most important topical treatments for psoriasis are vitamin D3 analogues and/or corticosteroids. The possibility of another effective treatment for psoriasis could be based on the immunosuppressive efficacy of selective blockers of a lymphocyte potassium channel. The aim of the clinical trial is to evaluate the safety, tolerability and anti-psoriatic efficacy of topical SPS4251 formulations in comparison to placebo and to a marketed topical Vitamin-D analogue ointment in a psoriasis plaque test.

Timeline

Start

2013-03

Primary completion

2013-07

Completion

2013-07

Drugs

Indications